When was Brainomix founded?

Brainomix was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is Brainomix located?

Brainomix is headquartered in Oxford, United Kingdom.

Who is the current CEO of Brainomix?

Michalis Papadakis of Brainomix. They have also founded 1 company.

Which legal entities is Brainomix associated with?

Brainomix is associated with BRAINOMIX LIMITED and 1 other.

How many employees does Brainomix have?

As of Sep 30, 2026, the latest employee count at Brainomix is 89.

Is Brainomix a funded company?

Brainomix is a funded company, having raised a total of $63.3M across 9 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Sep 26, 2014.

How much is Brainomix worth?

The latest valuation of Brainomix is £***** as of Oct 24, 2025.

When was the latest funding round of Brainomix?

Brainomix's latest funding was a $***** Series C round on Oct 24, 2025, with participation from 2 investors.

What is the annual revenue of Brainomix?

Annual revenue of Brainomix is between £1M and £10M as on Dec 31, 2025

Where does Brainomix rank among its competitors?

Brainomix ranks 7th amongst 1503 active competitors, of which 219 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Carpl, which secured $10M in Jul, 2026.

Who are the top competitors of Brainomix?

Brainomix's top competitors include Qure.ai, AIdoc and Oxipit. Among them, Carpl secured the most recent funding round in July, 2026.

Brainomix - 2026 Company Profile, Team, Funding, Competitors & Financials

Brainomix is a series C company based in Oxford (United Kingdom), founded in 2010 by Andrew Charles Barker, Michalis Papadakis and Michael Printzos. It operates as a Developer of automated medical imaging software for stroke and lung. Brainomix has raised $63.3M in funding from investors like Parkwalk, Boehringer Ingelheim Venture Fund and Boehringer Ingelheim, with a current valuation of £*****. The company has 1503 active competitors, including 219 funded and 56 that have exited. Its top competitors include companies like Qure.ai, AIdoc and Oxipit.

Company Details

Developer of automated medical imaging software for stroke and lung. This technology processes medical scans to identify biomarkers and assist in clinical assessment. The software provides automated analysis for stroke detection and lung disease evaluation. These tools support diagnostic workflows by generating insights from imaging data to assist in treatment decisions.

Website: www.brainomix.com/
Social
Email ID: *****@brainomix.com
Phone Number: +44 **********

Key Metrics

Founded Year

2010

Location

Oxford, United Kingdom

Stage

Series C

Total Funding

$63.3M in 9 rounds

Latest Funding Round

Series C, Oct 24, 2025, $*****

Post Money Valuation

£***** as on Oct 24, 2025

Investors

Parkwalk & 17 more

Ranked

7^th among 1503 active competitors

Annual Revenue

£1M - £10M as on Dec 31, 2025

Employee Count

89 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3820 more

View Brainomix's full profile

Brainomix is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Brainomix Limited CIN: 0788.872.492 , Belgium, Active	Jul 01, 2022	-	-	-
BRAINOMIX LIMITED CIN: 7426406 , Germany, Active	Nov 01, 2010	£1M - £10M (As on Dec 31, 2025)	29 (As on Dec 31, 2019)

Brainomix has raised a total funding of $63.3M over 9 rounds. Its first funding round was on Sep 26, 2014. Its latest funding round was a Series C round on Oct 24, 2025 for $*****. 2 investors participated in its latest round. Brainomix has 16 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Brainomix:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 24, 2025	5494935	Series C	7271327	2350304	6919795	7943063
Jan 06, 2025	4025886	Series C	8427992	6504568	8406736	IP Group
May 26, 2023	3540531	Series B	7590475	3810814	8237546	9251608

Access funding benchmarks and valuations. Sign up today!

View details of Brainomix's funding rounds and investors

The founders of Brainomix are Andrew Charles Barker, Michalis Papadakis and Michael Printzos. Michalis Papadakis is the CEO of Brainomix.

Here are the details of Brainomix's key team members:

Andrew Charles Barker: Former Co-Founder of Brainomix. They serve on the board of 1 company.
Michalis Papadakis: Co-Founder & CEO of Brainomix. They serve on the board of 1 company.
Contact Info: 1 email address
Michael Printzos: Co-founder of Brainomix.

Brainomix's Board of Directors

Brainomix's board has 6 active members. Andrew Charles Barker and Michalis Papadakis are part of team and Heinz-otto Peitgen, Ann Jacqueline Naylor, Mark Thomas Jaffray and Frank Kalkbrenner are independent board members.

Here is the list of Brainomix's board of directors:

Name	Type	Representing	Status	Duration
Andrew Charles Barker	Team	-	Current	12y 5m
Michalis Papadakis	Team	-	Current	15y 10m
Heinz-otto Peitgen	Independent board member	-	Current	6y 1m
vpatqqt	Independent board member	-	Current	6y 7m
tjabwsg	Independent board member	-	Current	7y 7m
emzjnlu	Independent board member	-	Current	2y 7m
zsjezsw	Independent board member	-	Past	9y 9m

View details of Brainomix's Founder profiles and Board Members

Brainomix's employee count trend

Brainomix has 89 employees as of Sep 26. Here is Brainomix's employee count trend over the years:

Uncover Brainomix's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Brainomix include Qure.ai, AIdoc and Oxipit. Here is the list of Top 10 competitors of Brainomix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Qure.ai 2016, Mumbai (India), Series D	Developer of artificial intelligence software for medical imaging diagnostic analysis	$123M	HealthQuad, 360 One & 47 others	74/100
2nd	AIdoc 2016, New York City (United States), Series E	Developer of clinical AI solutions for healthcare imaging and patient management	$534M	AIC, General Catalyst & 35 others	69/100
3rd	Oxipit 2017, Vilnius (Lithuania), Acquired	Developer of medical imaging software for automated radiology diagnostic support	$6.69M	Practica Capital, CoInvest Capital & 4 others	66/100
4th	Subtle Medical 2017, Palo Alto (United States), Series C	AI-driven solutions for medical diagnostic imaging	$86M	Morgan Stanley, 3E Bioventures Capital & 27 others	65/100
5th	Gleamer 2017, Paris (France), Acquired	Developer of artificial intelligence software for medical imaging diagnostic analysis	$40M	Elaia, XAnge & 11 others	65/100
6th	ScreenPoint 2014, Nijmegen (Netherlands), Series C	Developer of artificial intelligence software for analyzing breast imaging mammograms	$47M	Siemens, Insight Partners & 3 others	64/100
7th	Brainomix 2010, Oxford (United Kingdom), Series C	Developer of automated medical imaging software for stroke and lung	$63.3M	Boehringer Ingelheim Venture Fund, IP Group ... & 16 others	64/100
8th	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
9th	Carpl 2018, Cupertino (United States), Series A	Provider of an enterprise imaging platform that streamlines radiology workflows through a unified marketplace of artificial intelligence applications	$16M	IFC, Stellaris Venture Partners & 2 others	63/100
10th	Vista 2012, Palo Alto (United States), Series B	AI-guided software for clinicians to automate MRI exams	$38.2M	Open Field Capital, Khosla Ventures & 12 others	62/100